Suspended PHASE4 INTERVENTIONAL 2-arm NCT04248361

TEM-PCR™ Prospective Clinical Utility Study

A Randomized, Open-label, Multi-Center, Prospective Study to Assess the Clinical Utility of TEM-PCR™ Upper Respiratory Panel in Adult Patients 65 and Older Presenting With Symptoms of Acute Respiratory Illness

Sponsor: Diatherix Laboratories, LLC

Conditions Upper Resp Tract Infection

Interventions SOC/Empiric Diagnosis TEM-PCR URI Panel

Updated 7 times since 2020 Last updated: Aug 19, 2021 Started: Mar 6, 2020 Primary completion: May 31, 2022 Completion: May 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Low enrollment due to COVID-19

A PHASE4 clinical study on Upper Resp Tract Infection, this trial is suspended. The trial is conducted by Diatherix Laboratories, LLC and has accumulated 7 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Suspended PHASE4
Jul 2024 — Sep 2024 [monthly]

Suspended PHASE4
Sep 2021 — Jul 2024 [monthly]

Suspended PHASE4
May 2021 — Sep 2021 [monthly]

Suspended PHASE4
Jan 2021 — May 2021 [monthly]

Suspended PHASE4

▶ Show 2 earlier versions

Aug 2020 — Jan 2021 [monthly]

Suspended PHASE4

Status: Not Yet Recruiting → Suspended
Feb 2020 — Aug 2020 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Diatherix Laboratories, LLC

Data source: Diatherix Laboratories, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, United States
• Huntsville, United States